Impact of Serum γ-Glutamyltransferase on Overall Survival in Men with Metastatic Castration-Resistant Prostate Cancer Treated with Docetaxel.
Minami UneKosuke TakemuraKentaro InamuraHiroshi FukushimaMasaya ItoShuichiro KobayashiTakeshi YuasaJunji YonesePhilip G BoardFumitaka KogaPublished in: Cancers (2021)
Serum GGT may be a prognostic biomarker in men with mCRPC receiving docetaxel therapy. GGT overexpression by prostate cancer cells appears to be responsible for the elevation of GGT in the serum.